Prot #EP0012: An Open-Label, Multicenter Extension Study to Evaluate the Long-Term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects with Idiopathic Generalized Epilepsy